Frailty in Heart Failure According to the Presence or Absence of Wild-Type Transthyretin Cardiac Amyloidosis
ATTRwt CA is associated with a specific frailty phenotype. Patients with ATTRwt CA should be screened for frailty and managed collaboratively by cardiologists and geriatricians, with a view to improving quality of life.
Authors
- Luc Hittinger (ORCID: https://orcid.org/0000-0003-1933-5815)
- Nina Liu
- Arnault Galat (ORCID: https://orcid.org/0009-0000-8260-143X)
- Charlotte Lafont (ORCID: https://orcid.org/0000-0002-5019-9914)
- Mounira Kharoubi (ORCID: https://orcid.org/0000-0001-8942-2506)
- Thibaud Damy (ORCID: https://orcid.org/0000-0003-4058-3848)
- Amaury Broussier (ORCID: https://orcid.org/0000-0003-1137-9864)
- Sylvie Bastuji‐Garin (ORCID: https://orcid.org/0000-0001-9855-5183)
- Emmanuel Teíger (ORCID: https://orcid.org/0000-0001-7515-4344)
- Silvia Oghina (ORCID: https://orcid.org/0000-0003-0108-5598)
- Marie Paugam
- Amira Zaroui (ORCID: https://orcid.org/0000-0002-4827-4057)
- Jean Philippe David
Institutions
- Inserm (FR)
- Université Paris-Est Créteil (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Institut Mondor de Recherche Biomédicale (FR)
- Stony Brook University (US)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1002/ehf2.15026
- Citations
- 5
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.17